Cargando…
Prevalence of comorbid asthma in COVID-19 patients
Autores principales: | Butler, Marcus W., O’Reilly, Aoife, Dunican, Eleanor M., Mallon, Patrick, Feeney, Eoin R., Keane, Michael P., McCarthy, Cormac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284278/ https://www.ncbi.nlm.nih.gov/pubmed/32553599 http://dx.doi.org/10.1016/j.jaci.2020.04.061 |
Ejemplares similares
-
Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
por: O'Carroll, Orla, et al.
Publicado: (2020) -
Management of comorbidities in difficult and severe asthma
por: Khan, Jehangir, et al.
Publicado: (2023) -
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
por: Feeney, Eoin, et al.
Publicado: (2020) -
The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
por: O’Reilly, Aoife, et al.
Publicado: (2021) -
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
por: Cotter, Aoife, et al.
Publicado: (2020)